WHO adds two experimental Bundibugyo Ebola vaccines to DRC trial
The World Health Organization has recommended adding two experimental vaccines—ChAdOx1 (developed by the University of Oxford and Serum Institute of India) and Moderna's mRNA-1469—to an ongoing clinical trial in the Democratic Republic of Congo targeting the Bundibugyo strain of Ebola, marking the first evaluation of vaccines specifically designed against this strain during an outbreak.
5 November 2026 · Capital News →